CNBCLean R·
Novo's new strategy hinges on something it can't manufacture: investor trust
Novo has now reached the point where it can broaden its ambitions again, CEO Mike Doustdar told CNBC, but investors remain unconvinced.
Read at CNBC →
Novo has now reached the point where it can broaden its ambitions again, CEO Mike Doustdar told CNBC, but investors remain unconvinced.
<iframe src="https://statesidedaily.com/embed/cluster/e27fcb6d607386cba6943506b4547754fd7f4bf0" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Novo's new strategy hinges on something it can't manufacture: investor trust"></iframe>